To determine whether there was a difference between epinephrine and norepinephrine in achieving a mean arterial pressure (MAP) goal in intensive care (ICU) patients.
Prospective, double-blind, randomised-controlled trial.
Four Australian university-affiliated multidisciplinary ICUs.
Patients and participants
Patients who required vasopressors for any cause at randomisation. Patients with septic shock and acute circulatory failure were analysed separately.
Blinded infusions of epinephrine or norepinephrine to achieve a MAP ≥70 mmHg for the duration of ICU admission.
Primary outcome was achievement of MAP goal >24 h without vasopressors. Secondary outcomes were 28 and 90-day mortality. Two hundred and eighty patients were randomised to receive either epinephrine or norepinephrine. Median time to achieve the MAP goal was 35.1 h (interquartile range (IQR) 13.8–70.4 h) with epinephrine compared to 40.0 h (IQR 14.5–120 h) with norepinephrine (relative risk (RR) 0.88; 95% confidence interval (CI) 0.69–1.12; P = 0.26). There was no difference in the time to achieve MAP goals in the subgroups of patients with severe sepsis (n = 158; RR 0.81; 95% CI 0.59–1.12; P = 0.18) or those with acute circulatory failure (n = 192; RR 0.89; 95% CI 0.62–1.27; P = 0.49) between epinephrine and norepinephrine. Epinephrine was associated with the development of significant but transient metabolic effects that prompted the withdrawal of 18/139 (12.9%) patients from the study by attending clinicians. There was no difference in 28 and 90-day mortality.
Despite the development of potential drug-related effects with epinephrine, there was no difference in the achievement of a MAP goal between epinephrine and norepinephrine in a heterogenous population of ICU patients.
This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Tax calculation will be finalised during checkout.
Magder S, Rastepagarnah M (1998) Role of neurosympathetic pathways in the vascular response to sepsis. J Crit Care 13:169–176
Hein L (2006) Adrenoceptors and signal transduction in neurons. Cell Tissue Res 326:541–551
Myburgh JA (2002) The systemic and cerebrovascular effects of inotropes and vasopressors. In: Gullo A (ed) APICE: anaesthesia. Pain intensive care and emergency medicine. Springer, Milan, pp 283–299
Briegel J, Forst H, Haller M, Schelling G, Kilger E, Kuprat G, Hemmer B, Hummel T, Lenhart A, Heyduck M, Stoll C, Peter K (1999) Stress doses of hydrocortisone reverse hyperdynamic septic shock: a prospective, randomized, double-blind, single-center study. Crit Care Med 27:723–732
Annane D, Vignon P, Renault A, Bollaert PE, Charpentier C, Martin C, Troche G, Ricard JD, Nitenberg G, Papazian L, Azoulay E, Bellissant E (2007) Norepinephrine plus dobutamine versus epinephrine alone for management of septic shock: a randomised trial. Lancet 370:676–684
Meier-Hellmann A, Reinhart K, Bredle DL, Specht M, Spies CD, Hannemann L (1997) Epinephrine impairs splanchnic perfusion in septic shock. Crit Care Med 25:399–404
Levy B, Bollaert PE, Lucchelli JP, Sadoune LO, Nace L, Larcan A (1997) Dobutamine improves the adequacy of gastric mucosal perfusion in epinephrine-treated septic shock. Crit Care Med 25:1649–1654
De Backer D, Creteur J, Silva E, Vincent JL (2003) Effects of dopamine, norepinephrine, and epinephrine on the splanchnic circulation in septic shock: which is best? Crit Care Med 31:1659–1667
Day NP, Phu NH, Bethell DP, Mai NT, Chau TT, Hien TT, White NJ (1996) The effects of dopamine and adrenaline infusions on acid-base balance and systemic haemodynamics in severe infection. Lancet 348:219–223
Totaro RJ, Raper RF (1997) Epinephrine-induced lactic acidosis following cardiopulmonary bypass. Crit Care Med 25:1693–1699
Dellinger RP, Vincent JL (2005) The Surviving Sepsis Campaign sepsis change bundles and clinical practice. Crit Care 9:653–654
Lipman J, Roux A, Kraus P (1991) Vasoconstrictor effects of adrenaline in human septic shock. Anaesth Intensive Care 19:61–65
Wilson W, Lipman J, Scribante J, Kobilski S, Lee C, Krause P, Cooper J, Barr J (1992) Septic shock: does adrenaline have a role as a first-line inotropic agent? Anaesth Intensive Care 20:470–474
Myburgh JA, Higgins A, Jovanovska A, Lipman J, Santamaria J, Ramakrishnan N, the CAT Study Investigators (2007) A comparison of epinephrine and norepinephrine on reversal of shock. Intensive Care Med 33:S197
Myburgh JA (2003) Inotropic agents. In: Oh TE, Bersten AD, Soni N (eds) Intensive care manual. Butterworths, London, pp 841–855
Knaus WA, Draper EA, Wagner DP, Zimmerman JE (1985) APACHE II: a severity of disease classification system. Crit Care Med 13:818–829
Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, Schein RM, Sibbald WJ (1992) Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 101:1644–1655
Vincent JL, de Mendonca A, Cantraine F, Moreno R, Takala J, Suter PM, Sprung CL, Colardyn F, Blecher S (1998) Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicenter, prospective study. Working group on “sepsis-related problems” of the European Society of Intensive Care Medicine. Crit Care Med 26:1793–1800
Moeschberger ML, Klein JP (1995) Statistical methods for dependent competing risks. Lifetime Data Anal 1:195–204
Satagopan JM, Ben Porat L, Berwick M, Robson M, Kutler D, Auerbach AD (2004) A note on competing risks in survival data analysis. Br J Cancer 91:1229–1235
Minini P, Chavance M (2004) Sensitivity analysis of longitudinal normal data with drop-outs. Stat Med 23:1039–1054
Clark DE, Ryan LM (1997) Modeling injury outcomes using time-to-event methods. J Trauma 42:1129–1134
Mullner M, Urbanek B, Havel C, Losert H, Waechter F, Gamper G (2004) Vasopressors for shock. Cochrane Database Syst Rev:CD003709
Day NP, Phu NH, Mai NT, Bethell DB, Chau TT, Loc PP, Chuong LV, Sinh DX, Solomon T, Haywood G, Hien TT, White NJ (2000) Effects of dopamine and epinephrine infusions on renal hemodynamics in severe malaria and severe sepsis. Crit Care Med 28:1353–1362
Watt M, Howlett KF, Febbraio MA, Spriet LL, Hargreaves M (2001) Adrenaline increases skeletal muscle glycogenolysis, pyruvate dehydrogenase activation and carbohydrate oxidation during moderate exercise in humans. J Physiol 534:269–278
Levy B, Gibot S, Franck P, Cravoisy A, Bollaert PE (2005) Relation between muscle Na + K + ATPase activity and raised lactate concentrations in septic shock: a prospective study. Lancet 365:871–875
We wish to acknowledge funding for statistical analysis of this study from the Australian and New Zealand College of Anaesthetists (Project grant: 06/024). We also acknowledge the financial contribution from participating institutions that provided substantial support from internal funds. We acknowledge Gordon Doig for assistance with initial study design, Andrew Forbes for assistance with the statistical analysis plan, and Rinaldo Bellomo and Simon Finfer for editorial comment. We also thank the nursing and medical staff of the four ICUs of the participating institutions whose enthusiasm and hard work made the CAT study possible.
Conflict of interest statement
The investigators declare no conflicts of interest relating to this study.
About this article
Cite this article
Myburgh, J.A., Higgins, A., Jovanovska, A. et al. A comparison of epinephrine and norepinephrine in critically ill patients. Intensive Care Med 34, 2226 (2008). https://doi.org/10.1007/s00134-008-1219-0